S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
10-Q: Quarterly report
8-K: Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K: Current report
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 10-K: Annual report
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K: Current report
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K: Current report
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | NT 10-K: Others
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laxminarayan Bhat(10.2%)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%), etc.
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(6.32%),Steven Boyd(6.32%)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | EFFECT: Others
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 424B4: Prospectus
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | CORRESP: CORRESP
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | UPLOAD: Others
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | S-3: Registration statement for specified transactions by certain issuers
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Parag Saxena(19.9%),Vedanta Partners, LLC(19.4%), etc.
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director SAXENA PARAG
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K: Current report
No Data